Croda International Plc (LON:CRDA – Get Free Report) has been given an average rating of “Moderate Buy” by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is GBX 3,140.
A number of brokerages recently weighed in on CRDA. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 3,000 target price on shares of Croda International in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating for the company in a research note on Tuesday, March 24th. Finally, Morgan Stanley upgraded shares of Croda International to an “overweight” rating and increased their price objective for the stock from GBX 3,280 to GBX 3,350 in a research note on Wednesday, March 25th.
Check Out Our Latest Analysis on CRDA
Insider Transactions at Croda International
Croda International Price Performance
Shares of LON CRDA opened at GBX 2,828 on Thursday. The firm has a market cap of £3.94 billion, a PE ratio of 63.69, a PEG ratio of 1.40 and a beta of 0.90. The company has a current ratio of 1.99, a quick ratio of 2.25 and a debt-to-equity ratio of 31.85. Croda International has a 1-year low of GBX 2,426.77 and a 1-year high of GBX 3,312. The company has a fifty day moving average price of GBX 2,834.86 and a 200 day moving average price of GBX 2,816.26.
Croda International (LON:CRDA – Get Free Report) last announced its earnings results on Tuesday, February 24th. The company reported GBX 146.20 earnings per share for the quarter. Croda International had a net margin of 3.65% and a return on equity of 2.82%. Research analysts predict that Croda International will post 181.8307268 earnings per share for the current fiscal year.
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Read More
- Five stocks we like better than Croda International
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
